Andrea Mazza Beliero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrea Mazza Beliero has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Gdayllon Cavalcante Meneses
Universidade Federal do Ceará
4 shared publications - Polianna Lemos Moura Moreira Albuquerque
Charles Darwin University Australia, Australia
4 shared publications - Ana Paula Pires Lázaro
Universidade de Fortaleza, Brasil
3 shared publications - Geraldo Bezerra da Silva Junior
Universidade de Fortaleza
3 shared publications - Marza de Sousa Zaranza
Prefeitura Municipal Fortaleza, Inst Dr Jose Frota, Fortaleza, Ceara, Brazil
3 shared publications - Nilcyeli Linhares Aragao
Univ Fed Ceara, Fac Med, Dept Med Interna, Programa Posgrad Ciencias Med, Fortaleza, Ceara, Brazil
3 shared publications
Latest Publications
- Open Access
- 11 July 2025
- Published by Universidade Federal do Ceará (UFC) in Revista de Medicina da UFC
- Vol. 65, e83512
Desigualdades sociais e mortalidade na COVID-19: estudo transversal no nordeste do Brasil
Objetivo: Analisar a associação entre as desigualdades sociais e condições socioeconômicas e a mortalidade por COVID-19 em Unidade de Terapia Intensiva de um hospital do nordeste brasileiro, de abril de 2020 a junho de 2021. Métodos: estudo transversal, descritivo e analítico realizado com casos confirmados de COVID-19 através de amostra por conveniência de 235 pacientes. Na análise descritiva utilizaram-se frequências absolutas e percentuais, média, mediana e desvio padrão. Na inferencial utilizou-se o teste de qui-quadrado de Wald, considerando-se p<0,20. No modelo ajustado utilizou-se a regressão de Poisson com p <0,05. O teste de Omnibus verificou a significância do modelo ajustado. O teste t de student comparou categorias/grupos. Resultados: dos 235 pacientes a maioria teve óbito como desfecho (63,8%), eram do sexo masculino (60,8%), idade igual ou maior a 60 anos (51,1%) e com comorbidade (64,7%). Tempo do início dos sintomas até a internação igual ou maior que nove dias (53,6%), fez uso de suporte ventilatório invasivo (64,7%) com tempo de internação igual ou maior que 9 dias (70,6%). Na análise espacial os óbitos ocorreram naqueles provenientes de áreas desfavorecidas. Conclusão: a mortalidade hospitalar observada foi consistente com as desigualdades no acesso aos cuidados de saúde de qualidade durante a pandemia.
- 11 July 2025
- Published by Universidade Federal do Ceará (UFC) in Revista de Medicina da UFC
- Vol. 65, e83512
Open AccessDesigualdades sociais e mortalidade na COVID-19: estudo transversal no nordeste do Brasil
Objetivo: Analisar a associação entre as desigualdades sociais e condições socioeconômicas e a mortalidade por COVID-19 em Unidade de Terapia Intensiva de um hospital do nordeste brasileiro, de abril de 2020 a junho de 2021. Métodos: estudo transversal, descritivo e analítico realizado com casos confirmados de COVID-19 através de amostra por conveniência de 235 pacientes. Na análise descritiva utilizaram-se frequências absolutas e percentuais, média, mediana e desvio padrão. Na inferencial utilizou-se o teste de qui-quadrado de Wald, considerando-se p<0,20. No modelo ajustado utilizou-se a regressão de Poisson com p <0,05. O teste de Omnibus verificou a significância do modelo ajustado. O teste t de student comparou categorias/grupos. Resultados: dos 235 pacientes a maioria teve óbito como desfecho (63,8%), eram do sexo masculino (60,8%), idade igual ou maior a 60 anos (51,1%) e com comorbidade (64,7%). Tempo do início dos sintomas até a internação igual ou maior que nove dias (53,6%), fez uso de suporte ventilatório invasivo (64,7%) com tempo de internação igual ou maior que 9 dias (70,6%). Na análise espacial os óbitos ocorreram naqueles provenientes de áreas desfavorecidas. Conclusão: a mortalidade hospitalar observada foi consistente com as desigualdades no acesso aos cuidados de saúde de qualidade durante a pandemia.
- Open Access
- 26 December 2023
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 49 (6) , e20230227
ELMO CPAP: an innovative type of ventilatory support for COVID-19-related acute respiratory distress syndrome
Objective: To assess whether the use of ELMO, a helmet for noninvasive ventilation created in Brazil, had a positive impact on the prognosis of patients with hypoxemic respiratory failure caused by severe COVID-19. Methods: This is a retrospective study of 50 critically ill COVID-19 patients. Epidemiological, clinical, and laboratory data were collected on ICU admission, as well as before, during, and after ELMO use. Patients were divided into two groups (success and failure) according to the outcome. Results: ELMO use improved oxygenation parameters such as Pao(2), Fio(2), and the Pao(2)/Fio(2) ratio, and this contributed to a gradual reduction in Fio 2, without an increase in CO2, as determined by arterial blood gas analysis. Patients in the success group had significantly longer survival (p < 0.001), as determined by the Kaplan-Meier analysis, less need for intubation (p < 0.001), fewer days of hospitalization, and a lower incidence of acute kidney injury in comparison with those in the failure group. Conclusions: The significant improvement in oxygenation parameters, the longer survival, as reflected by the reduced need for intubation and by the mortality rate, and the absence of acute kidney injury suggest that the ELMO CPAP system is a promising tool for treating ARDS and similar clinical conditions.
- 26 December 2023
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 49 (6) , e20230227
Open AccessELMO CPAP: an innovative type of ventilatory support for COVID-19-related acute respiratory distress syndrome
Objective: To assess whether the use of ELMO, a helmet for noninvasive ventilation created in Brazil, had a positive impact on the prognosis of patients with hypoxemic respiratory failure caused by severe COVID-19. Methods: This is a retrospective study of 50 critically ill COVID-19 patients. Epidemiological, clinical, and laboratory data were collected on ICU admission, as well as before, during, and after ELMO use. Patients were divided into two groups (success and failure) according to the outcome. Results: ELMO use improved oxygenation parameters such as Pao(2), Fio(2), and the Pao(2)/Fio(2) ratio, and this contributed to a gradual reduction in Fio 2, without an increase in CO2, as determined by arterial blood gas analysis. Patients in the success group had significantly longer survival (p < 0.001), as determined by the Kaplan-Meier analysis, less need for intubation (p < 0.001), fewer days of hospitalization, and a lower incidence of acute kidney injury in comparison with those in the failure group. Conclusions: The significant improvement in oxygenation parameters, the longer survival, as reflected by the reduced need for intubation and by the mortality rate, and the absence of acute kidney injury suggest that the ELMO CPAP system is a promising tool for treating ARDS and similar clinical conditions.
- 28 October 2023
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 118 (3) , 160-169
Syndecan-1 levels predict septic shock in critically ill patients with COVID-19
Background: The clinical picture of coronavirus disease 2019 (COVID-19)-associated sepsis is similar to that of sepsis of other aetiologies. The present study aims to analyse the role of syndecan-1 (SDC-1) as a potential predictor of septic shock in critically ill patients with COVID-19. Methods: This is a prospective study of 86 critically ill patients due to COVID-19 infection. Patients were followed until day 28 of hospitalization. Vascular biomarkers, such as vascular cell adhesion protein-1, SDC-1, angiopoietin-1 and angiopoietin-2, were quantified upon admission and associated with the need for vasopressors in the first 7 d of hospitalization. Results: A total of 86 patients with COVID-19 (mean age 60±16 y; 51 men [59%]) were evaluated. Thirty-six (42%) patients died during hospitalization and 50 (58%) survived. The group receiving vasopressors had higher levels of D-dimer (2.46 ng/ml [interquartile range {IQR} 0.6–6.1] vs 1.01 ng/ml [IQR 0.62–2.6], p=0.019) and lactate dehydrogenase (929±382 U/l vs 766±312 U/l, p=0.048). The frequency of deaths during hospitalization was higher in the group that received vasoactive amines in the first 24 h in the intensive care unit (70% vs 30%, p=0.002). SDC-1 levels were independently associated with the need for vasoactive amines, and admission values >269 ng/ml (95% CI 0.524 to 0.758, p=0.024) were able to predict the need for vasopressors during the 7 d following admission. Conclusions: Syndecan-1 levels predict septic shock in critically ill patients with COVID-19.
- 28 October 2023
- Published by Oxford University Press (OUP) in Transactions of the Royal Society of Tropical Medicine and Hygiene
- Vol. 118 (3) , 160-169
Syndecan-1 levels predict septic shock in critically ill patients with COVID-19
Background: The clinical picture of coronavirus disease 2019 (COVID-19)-associated sepsis is similar to that of sepsis of other aetiologies. The present study aims to analyse the role of syndecan-1 (SDC-1) as a potential predictor of septic shock in critically ill patients with COVID-19. Methods: This is a prospective study of 86 critically ill patients due to COVID-19 infection. Patients were followed until day 28 of hospitalization. Vascular biomarkers, such as vascular cell adhesion protein-1, SDC-1, angiopoietin-1 and angiopoietin-2, were quantified upon admission and associated with the need for vasopressors in the first 7 d of hospitalization. Results: A total of 86 patients with COVID-19 (mean age 60±16 y; 51 men [59%]) were evaluated. Thirty-six (42%) patients died during hospitalization and 50 (58%) survived. The group receiving vasopressors had higher levels of D-dimer (2.46 ng/ml [interquartile range {IQR} 0.6–6.1] vs 1.01 ng/ml [IQR 0.62–2.6], p=0.019) and lactate dehydrogenase (929±382 U/l vs 766±312 U/l, p=0.048). The frequency of deaths during hospitalization was higher in the group that received vasoactive amines in the first 24 h in the intensive care unit (70% vs 30%, p=0.002). SDC-1 levels were independently associated with the need for vasoactive amines, and admission values >269 ng/ml (95% CI 0.524 to 0.758, p=0.024) were able to predict the need for vasopressors during the 7 d following admission. Conclusions: Syndecan-1 levels predict septic shock in critically ill patients with COVID-19.
- Open Access
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 56, e12728
Predictors of mortality in critically ill patients with COVID-19 and diabetes
The COVID-19 pandemic has challenged the entire world, and patients with diabetes mellitus (DM) have been particularly affected. We aimed to evaluate predictors of mortality during the first 30 days of hospitalization in critically ill patients with COVID-19 and comorbid DM. This prospective study included 110 critically ill patients admitted with COVID-19 infection. Thirty-two (29%) patients had a previous diagnosis of DM. Clinical variables, laboratory tests, and vascular biomarkers, such as VCAM-1, syndecan-1, ICAM-1, angiopoietin-1, and angiopoeitin-2, were evaluated after intensive care unit (ICU) admission. A comparison was made between patients with and without DM. No difference in mortality was observed between the groups (48.7 vs 46.9%, P=0.861). In the multivariate Cox regression analysis, VCAM-1 levels at ICU admission (HR: 1 [1-1.001], P<0.006) were associated with death in patients with DM. Among patients with DM, advanced age (HR 1.063 [1.031-1.096], P<0.001), increased Ang-2/Ang-1 ratio (HR: 4.515 [1.803-11.308] P=0.001), and need for dialysis (HR: 3.489 [1.409-8.642], P=0.007) were independent predictors of death. Higher levels of VCAM-1 in patients with DM was better at predicting death of patients with severe COVID-19 and comorbid DM, and their cut-off values were useful for stratifying patients with a worse prognosis. Vascular biomarkers VCAM-1 and Ang-2/Ang-1 ratio were predictors of death in patients with severe COVID-19 and comorbid DM and those without DM. Additionally, kidney injury was associated with an increased risk of death.
- 1 January 2023
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 56, e12728
Open AccessPredictors of mortality in critically ill patients with COVID-19 and diabetes
The COVID-19 pandemic has challenged the entire world, and patients with diabetes mellitus (DM) have been particularly affected. We aimed to evaluate predictors of mortality during the first 30 days of hospitalization in critically ill patients with COVID-19 and comorbid DM. This prospective study included 110 critically ill patients admitted with COVID-19 infection. Thirty-two (29%) patients had a previous diagnosis of DM. Clinical variables, laboratory tests, and vascular biomarkers, such as VCAM-1, syndecan-1, ICAM-1, angiopoietin-1, and angiopoeitin-2, were evaluated after intensive care unit (ICU) admission. A comparison was made between patients with and without DM. No difference in mortality was observed between the groups (48.7 vs 46.9%, P=0.861). In the multivariate Cox regression analysis, VCAM-1 levels at ICU admission (HR: 1 [1-1.001], P<0.006) were associated with death in patients with DM. Among patients with DM, advanced age (HR 1.063 [1.031-1.096], P<0.001), increased Ang-2/Ang-1 ratio (HR: 4.515 [1.803-11.308] P=0.001), and need for dialysis (HR: 3.489 [1.409-8.642], P=0.007) were independent predictors of death. Higher levels of VCAM-1 in patients with DM was better at predicting death of patients with severe COVID-19 and comorbid DM, and their cut-off values were useful for stratifying patients with a worse prognosis. Vascular biomarkers VCAM-1 and Ang-2/Ang-1 ratio were predictors of death in patients with severe COVID-19 and comorbid DM and those without DM. Additionally, kidney injury was associated with an increased risk of death.